Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

AI-Driven Drug Firm METiS Eyes $200 Million Hong Kong IPO Amid Growing Biotech Momentum

by Team Lumida
May 12, 2025
in AI
Reading Time: 4 mins read
A A
0
AI Investment Boom: How Tech Giants Are Leading the Charge

"Machine Learning & Artificial Intelligence" by mikemacmarketing is licensed under CC BY 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • METiS Pharmaceuticals, an AI-driven drug discovery and delivery firm, is considering a Hong Kong IPO to raise up to $200 million by the end of 2025.
  • The company has raised $300 million in funding since its inception in 2020, with notable backers like CICC Capital, China Taiping Insurance, and HongShan (formerly Sequoia China).
  • METiS operates globally, with offices in Hangzhou, Beijing, Shanghai, and Cambridge, Massachusetts.
  • The IPO reflects growing investor interest in AI-powered biotech solutions, despite ongoing market uncertainties.

What Happened?

METiS Pharmaceuticals, a Hangzhou-based AI-driven drug discovery and delivery company, is reportedly planning an initial public offering (IPO) in Hong Kong to raise as much as $200 million. The company is working with advisers to finalize the IPO, which could take place before the end of 2025. While details such as the size and timing of the offering are still under discussion, METiS has not commented on the matter.

Since its founding in 2020, METiS has raised $300 million in funding, including a $100 million Series C round in June 2023 led by CICC Capital and supported by China Taiping Insurance and HongShan. The company has a global presence, with offices in China and the US.


Why It Matters?

METiS’s potential IPO highlights the growing intersection of artificial intelligence and biotechnology, a sector that has attracted significant investor interest due to its potential to revolutionize drug discovery and delivery. The $200 million IPO would provide METiS with additional capital to expand its operations and accelerate its AI-driven drug development initiatives.

The move also underscores Hong Kong’s appeal as a hub for biotech IPOs, particularly for Chinese firms seeking to tap into global capital markets. Despite broader market uncertainties, the biotech sector remains resilient, with investors drawn to its long-term growth potential.


What’s Next?

If METiS proceeds with the IPO, investors should monitor the company’s valuation, financial performance, and pipeline of AI-driven drug solutions. The success of the IPO could set a precedent for other AI-focused biotech firms considering public listings.

Additionally, the broader market environment, including geopolitical tensions and regulatory developments in Hong Kong, will play a critical role in shaping the outcome of this offering. Investors should also watch for updates on METiS’s partnerships and advancements in its drug discovery platform.

Source
Previous Post

US-China Tariff Reductions Signal Temporary Trade Truce, Markets React Positively

Next Post

Citi Predicts Stablecoins Will Expand Beyond Crypto, Reaching $1.6 Trillion by 2030

Recommended For You

Big Tech’s AI Capex Surges to $400B in 2025 and Rising in 2026

by Team Lumida
6 hours ago
Big Tech’s AI Capex Surges to $400B in 2025 and Rising in 2026

Key Takeaways Powered by lumidawealth.com Alphabet, Meta, Microsoft, and Amazon plan ~$400B AI spend in 2025; all guide higher for 2026. Capacity remains short; Microsoft says demand still outpaces...

Read more

OpenAI Weighs $1 Trillion IPO Target Amid Massive AI Buildout

by Team Lumida
1 day ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Key Takeaways Powered by lumidawealth.com Reuters reports OpenAI may pursue a 2026 IPO targeting a ~$1T valuation; company says an IPO is “not our focus.” Recent corporate restructuring makes...

Read more

Nvidia Becomes First $5 Trillion Company as AI Supercycle Accelerates

by Team Lumida
1 day ago
Nvidia’s Stock: Is It Too Good to Be True Now?

Key Takeaways Powered by lumidawealth.com Market cap hits ~$5.03T with shares at $207.16; first company to cross $5T. AI demand drives scale: ~6M Blackwell GPUs shipped; ~14M on order....

Read more

Alphabet Posts Record Quarter as AI Demand Lifts Cloud; Capex Guide Jumps to ~$93B

by Team Lumida
1 day ago
China Stimulus: Enough to Sway Markets?

Key Takeaways Powered by lumidawealth.com Q3 revenue rose 16% to $102.3B; net income up 33% to ~$35B; shares +6% after-hours. 2025 capex guided to $91–93B vs $52.5B in 2024,...

Read more

Nvidia CEO Downplays AI Bubble Fears as He Enlists New Partners

by Team Lumida
2 days ago
Nvidia’s AI Demand Surge: Hon Hai Ramps Up Server Production

Key Takeaways Powered by lumidawealth.com Nvidia CEO Huang announced flurry of partnerships at Washington GTC conference, said Blackwell/Rubin chips on track to generate $500B revenue through 2026. Expects to...

Read more

OpenAI’s Promise to Stay in California Helped Clear the Path for Its IPO

by Team Lumida
2 days ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Key Takeaways Powered by lumidawealth.com OpenAI CEO Altman assured California AG Bonta the company would stay in California and expand, clearing path for corporate restructuring and potential IPO as...

Read more

Qualcomm Launches AI Chips to Challenge Nvidia’s Dominance

by Team Lumida
3 days ago
Qualcomm Launches AI Chips to Challenge Nvidia’s Dominance

Key Takeaways Powered by lumidawealth.com Qualcomm shares jumped up to 20% Monday after announcing AI accelerator chips AI200 (shipping 2026) and AI250 (2027) to rival Nvidia; available as stand-alone...

Read more

AI-Power Stock Rally Shows Cracks as Investors Reassess Electricity Demand Surge

by Team Lumida
4 days ago
AI-Power Stock Rally Shows Cracks as Investors Reassess Electricity Demand Surge

Key Takeaways Powered by lumidawealth.com A UBS “AI power demand” basket fell 12% in five sessions, worst drop since February. Oklo plunged 30% and Vistra 12%, reflecting doubts about...

Read more

AWS Loses AI Edge: Outage, Anthropic–Google Chip Deal, and Rising Competitive Pressure

by Team Lumida
6 days ago
AWS Loses AI Edge: Outage, Anthropic–Google Chip Deal, and Rising Competitive Pressure

Key Takeaways Powered by lumidawealth.com 15-hour AWS outage disrupted major apps and services, highlighting reliability risk during a pivotal AI shift. Google will supply Anthropic up to 1M AI...

Read more

AI Infrastructure Boom Overshadows U.S. Manufacturing Revival

by Team Lumida
7 days ago
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Key Takeaways: Powered by lumidawealth.com U.S. factory construction spending is down 2.5% in 2025, while data center construction is up nearly 18%, driven by AI investment. Hyperscalers like Microsoft,...

Read more
Next Post
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Citi Predicts Stablecoins Will Expand Beyond Crypto, Reaching $1.6 Trillion by 2030

Can Apple’s Vision Pro Bounce Back with a Budget-Friendly Model?

Apple Weighs iPhone Price Hikes Amid Trade Risks and Supply Chain Shifts

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

deadline, debt, money

US Companies Slash Borrowing Costs on $400bn Junk Loans: What You Need to Know

June 27, 2024
UniCredit to Double Stake in Greek Bank Alpha Services to 20%, Adding €180 Million in Annual Profit

UniCredit to Double Stake in Greek Bank Alpha Services to 20%, Adding €180 Million in Annual Profit

May 28, 2025
Nvidia graphics processing unit

NVIDIA Earnings Highlights: Record-Breaking Quarter Fueled by AI Demand

August 29, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018